CM Life Sciences, Inc.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $442.75M |
|---|---|
| IPO Date | Sep 2, 2020 |
| CEO | Eli D. Casdin |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Sema4 |
| Deal Announced | Feb 10, 2021 |
| Deal Size, $M | $2,071.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 21, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jul 22, 2021 |
Formerly CMLF
WGS
SMFRW
| Price | $166.79 $5.05 |
|---|---|
| Last closing price | $167.52 |
| H/L, today | $162.25 / $170.75 |
| Volume, today | 158,232 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.